Oncomine Myeloid Research Assay leverages Thermo Fisher's next-generation sequencing to analyze 74 genes in a single panel and overcome hurdles of sequential-based clinical research

The proposed national coverage determination provides Medicare beneficiaries with reimbursable testing using multi-biomarker NGS IVD tests to better inform treatment decisions

Real-Time PCR workflow gains AOAC-RI approval for rapid and simultaneous detection of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis

New cas9 protein and synthetic gRNA strengthen Thermo Fisher Scientific's portfolio of genome editing products

Thermo Fisher Scientific customers also highlight their latest research advancements in solid tumor profiling and liquid biopsy analysis during corporate workshops

Newest library update adds 14 new forms of fentanyl to handheld narcotics analyzer, designed to rapidly identify emerging synthetic opioids and other potent drugs in the field

"Best Place to Work for LGBTQ Equality" for third consecutive year

Agreement to expand Oncomine Dx Target Test with RET fusion markers to treat non-small cell lung cancer patients

Enhancements to Thermo Scientific Orbitrap GC-MS Systems offer users unprecedented depth for comprehensive compound characterization

AmpliSeq On Demand NGS Panels nearly tripled to 3,000 genes for investigating inherited disease-causing variants

Coverage of the comprehensive, multi-biomarker test is now available to Regence BlueCross/BlueShield plan members in Oregon, Idaho, Utah and Washington

Cryo-electron microscopes are used to "see the molecules inside the cell and how they interact"

Seven Bright and Earthy Colorways Added to 32-Ounce Wide Mouth Collection

Thermo Scientific Niton XL5 handheld XRF analyzer now offers additional functionality and new accessories, including collapsible mini test stand